Skip to main content
news
REUTERS/Tingshu Wang

Freshfields Bruckhaus Deringer is advising Aquila Acquisition Corporation, a special purpose acquisition company (SPAC) jointly established by CMB International and AAC Mgmt Holding, on its planned IPO in Hong Kong, with Linklaters advising the joint sponsors.

This is Hong Kong’s first application under the new SPAC listing rules, which came into effect on Jan. 1. The Hong Kong Stock Exchange introduced SPAC new rules in December last year. If Aquila’s application is successful, it will become the first SPAC listed in Hong Kong.

Established in 2021, Aquila is registered in the Cayman Islands. According to the company’s prospectus, its key interest in acquisition of one or multiple companies targets Asian, especially Chinese, companies in the new economy such as green energy, life science, and advanced technology and manufacturing.

The Linklaters team is led by partners Gilbert Li and Lipton Li, with the Maples Group acting as offshore counsel to the issuer.

Related Articles

N&A, S&C, TMI advise as Japan's Nidec makes $1.6 bln bid for Makino Milling

TMI Associates, Freshfields and Davis Polk & Wardwell have represented Japanese manufacturing giant Nidec on its 257-billion-yen ($1.6 billion) bid for Makino Milling Machine, which turned to Nishimura & Asahi and Sullivan & Cromwell for advice.

N&A, MHM, Skadden, STB guide JX Advanced Metal’s $3 bln Japan IPO

by Nimitt Dixit |

Nishimura & Asahi and Skadden Arps Slate Meagher & Flom are advising JX Advanced Metals on its upcoming 460-billion-yen ($3 billion) initial public offering, the largest listing in Japan since SoftBank Corp’s $23.5 billion IPO in 2018.

Trilegal, Touchstone, CAM act on Carlyle’s $400 mln entry into India auto-components space

by Nimitt Dixit |

Trilegal has advised global private equity firm Carlyle on its acquisition of majority stakes in Highway Industries (HIL) and Roop Automotives for $400 million, marking its entry into India's auto components sector through a new manufacturing platform.